Evidence map›Paper›PMID 35256669›Full record

ArticleScientific reports2022

Evaluating COVID-19 control measures in mass gathering events with vaccine inequalities.

Ali M Al-Shaery, Bilal Hejase, Abdessamad Tridane, Norah S Farooqi, Hamad Al Jassmi

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali M Al-ShaeryDepartment of Civil Engineering, College of Engineering and Islamic Architecture, Umm Al-Qura University, Makkah, Saudi Arabia.
Bilal HejaseDepartment of Electrical Engineering, Ohio State University, Columbus, OH, 43210, USA.
Abdessamad TridaneMathematical Sciences Department, College of Science, United Arab Emirates University, Al Ain, UAE. a-tridane@uaeu.ac.ae.
Norah S FarooqiCollege of Computer and Information Systems, Umm Al-Qura University, Makkah, Saudi Arabia.
Hamad Al JassmiEmirates Center for Mobility Research, United Arab Emirates University, Al Ain, UAE.

Funding

Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia RDO-P543
6 · The paper itself

Abstract

With the increasing global adoption of COVID-19 vaccines, limitations on mass gathering events have started to gradually loosen. However, the large vaccine inequality recorded among different countries is an important aspect that policymakers must address when implementing control measures for such events. In this paper, we propose a model for the assessment of different control measures with the consideration of vaccine inequality in the population. Two control measures are considered: selecting participants based on vaccine efficacy and restricting the event capacity. We build the model using agent-based modeling to capture the spatiotemporal crowd dynamics and utilize a genetic algorithm to assess the control strategies. This assessment is based on factors that are important for policymakers such as disease prevalence, vaccine diversity, and event capacity. A quantitative evaluation of vaccine diversity using the Simpson's Diversity Index is also provided. The Hajj ritual is used as a case study. We show that strategies that prioritized lowering the prevalence resulted in low event capacity but facilitated vaccine diversity. Moreover, strategies that prioritized diversity resulted in high infection rates. However, increasing the prioritization of participants with high vaccine efficacy significantly decreased the disease prevalence. Strategies that prioritized ritual capacity did not show clear trends.

Indexed as

Mass GatheringsAlgorithmsCOVID-19COVID-19 VaccinesHumansIslamModels, StatisticalSaudi ArabiaCOVID-19 Vaccines

Identifiers

PMID35256669
PMCPMC8901904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.